ABVC logo

ABVC BioPharma (ABVC)

Profile

Full Name

ABVC BioPharma, Inc.

Ticker Symbol

ABVC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 10, 2004

Indexes

Not included

Website

http://www.abvcpharma.com

Employees

16

Key Details

Price

$0.91(-0.44%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$152.40K(-84.29% YoY)

Annual EPS

-$2.43(+53.18% YoY)

PE ratio

-

Next earnings date

May 16, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.91
ABVC price is $0.91

30-Day Relative Volume

0.41
ABVC 30-day relative volume is 0.41

Price Performance

Price Most recent change

-0.44%
ABVC price was down -0.44% on Apr 14, 2025

Price YTD change

+54.24%
ABVC price is up +54.24% since January 1st

Price 1-year change

-16.51%
ABVC price is down -16.51% year-on-year

Price 3-year change

-96.39%
ABVC price is down -96.39% over the past 3 years

Price Range

Price All-time high

$7165605.00
ABVC price is currently -100.00% below its historical high of $7165605.00

Price 3-year low

$0.40
ABVC price is currently +127.50% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$11.14M
ABVC market capitalization is $11.14 million

Market cap 3-year change

-85.41%
ABVC market capitalization is down -85.41% over the past 3 years

Market cap All-time high

$2.98B
ABVC market capitalization is currently -99.63% below its historical high of $2.98 billion

Market cap sector rank

21.22%
ABVC market capitalization is higher than 21.22% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+15.95%
ABVC shares outstanding is up +15.95% year-on-year

Shares Outstanding 3-Year Change

+304.02%
ABVC shares outstanding is up +304.02% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.70
ABVC beta is 0.70

200-day SMA

$0.65
ABVC price is currently +40.54% above its 200-day simple moving average

50-day SMA

$0.70
ABVC price is currently +29.96% above its 50-day simple moving average

RSI

53.62
ABVC 14-day relative strength index is 53.62

Volume

0.41
ABVC 30-day relative volume is 0.41

ATR

$0.16
ABVC average true range is $0.16

10-day Historical Volatility

238.34%
ABVC 10-day historical volatility is 238.34%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$152.40K
ABVC annual revenue is $152.40 thousand

Revenue Analysts estimate

-
ABVC annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-84.29%
ABVC annual revenue is down -84.29% year-on-year

Revenue Sector rank

6.16%
ABVC annual revenue is higher than 6.16% of companies in Healthcare sector

EPS

EPS

-$2.43
ABVC annual earnings per share is -$2.43

EPS Analysts estimate

-$0.44
ABVC annual earnings per share is currently +452.27% higher than the consensus analysts' forecast

EPS 1-year change

+53.18%
ABVC annual earnings per share is up +53.18% year-on-year

EPS Sector rank

34.49%
ABVC annual earnings per share is higher than 34.49% of companies in Healthcare sector

Profit

Gross profit

-$149.60K
ABVC annual gross profit is -$149.60 thousand

Gross margin

-98.15%
ABVC annual gross profit margin is -98.15%

Operating profit

-$8.22M
ABVC annual operating income is -$8.22 million

Operating margin

-5390.35%
ABVC annual operating profit margin is -5390.35%

Net income

-$10.52M
ABVC annual net profit is -$10.52 million

Net margin

-6898.68%
ABVC annual net profit margin is -6898.68%

Expenses

Total expenses

$8.37M
ABVC annual total expenses is $8.37 million

Operating expenses

$8.07M
ABVC annual total operating expenses is $8.07 million

Cost of goods sold

$302.00K
ABVC annual cost of goods sold is $302.00 thousand

Selling, general & administrative expenses

$7.00M
ABVC annual SGA is $7.00 million

Depreciation and amortization

$28.50K
ABVC annual depreciation & amortization is $28.50 thousand

Interest expense

$2.49M
ABVC annual interest expense is $2.49 million

Income tax

$256.00K
ABVC annual income tax is $256.00 thousand

EBIT & EBITDA

EBIT

-$8.16M
ABVC annual earnings before interest & taxes is -$8.16 million

EBITDA

-$8.13M
ABVC annual EBITDA is -$8.13 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$14.49M
ABVC annual total assets is $14.49 million

Non current assets

$12.84M
ABVC annual long term assets is $12.84 million

Current assets

$1.66M
ABVC annual total current assets is $1.66 million

Cash and cash equivalents

$60.20K
ABVC annual cash & cash equivalents is $60.20 thousand

Accounts receivable

$1500.00
ABVC annual accounts receivable is $1500.00

Inventory

-
ABVC annual inventory value is unknown

Liabilities

Total liabilities

$6.36M
ABVC annual total liabilities is $6.36 million

Long term liabilities

$429.10K
ABVC annual total long term liabilities is $429.10 thousand

Current liabilities

$5.93M
ABVC annual total current liabilities is $5.93 million

Accounts payable

-
ABVC annual accounts payable value is unknown

Debt

Total debt

$2.28M
ABVC annual total debt is $2.28 million

Total debt 1-year change

-25.43%
ABVC annual total debt is down -25.43% year-on-year

Long term debt

$407.50K
ABVC annual long term debt is $407.50 thousand

Short term debt

$1.87M
ABVC annual short term debt is $1.87 million

Equity & Capital

Shareholders equity

$8.39M
ABVC annual stockholders equity is $8.39 million

Book value

$8.39M
ABVC annual book value is $8.39 million

Retained earnings

-$65.42M
ABVC annual retained earnings is -$65.42 million

Working capital

-$4.28M
ABVC annual working capital is -$4.28 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$4.24M
ABVC annual cash flow from operations is -$4.24 million

Cash from operations 1-year change

+42.75%
ABVC annual cash flow from operations is up +42.75% year-on-year

Cash from investing

-$360.20K
ABVC annual cash flow from investing activities is -$360.20 thousand

Cash from investing 1-year change

+79.08%
ABVC annual cash flow from investing activities is up +79.08% year-on-year

Cash from financing

$3.92M
ABVC annual cash flow from financing activities is $3.92 million

Cash from financing 1-year change

-2.36%
ABVC annual cash flow from financing activities is down -2.36% year-on-year

CAPEX

CAPEX

$21.20K
ABVC annual capital expenditures is $21.20 thousand

CAPEX 1-year change

-82.29%
ABVC annual capital expenditures is down -82.29% year-on-year

Free Cash Flow

Free cash flow

-$4.26M
ABVC annual free cash flow is -$4.26 million

Free cash flow 1-year change

+43.38%
ABVC annual free cash flow is up +43.38% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-98.15%
ABVC annual gross profit margin is -98.15%

Operating margin

-5390.35%
ABVC annual operating profit margin is -5390.35%

Net margin

-6898.68%
ABVC annual net profit margin is -6898.68%

ROA & ROE

ROA

-87.37%
ABVC annual return on assets is -87.37%

ROE

-185.02%
ABVC annual return on equity is -185.02%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ABVC price to earnings ratio value is unknown

PE ratio Sector rank

-
ABVC price to earnings ratio is unknown

PB Ratio

PB ratio

1.33
ABVC price to book ratio is 1.33

PB ratio Sector rank

51.36%
ABVC price to book ratio is higher than 51.36% of companies in Healthcare sector

PS Ratio

PS ratio

21.86
ABVC price to sales ratio is 21.86

PS ratio Sector rank

87.05%
ABVC price to sales ratio is higher than 87.05% of companies in Healthcare sector

Enterprise value

Enterprise value

$13.33M
ABVC enterprise value is $13.33 million

Enterprise value Sector rank

28.1%
ABVC enterprise value is higher than 28.1% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.10
ABVC EV/EBITDA is -2.10

EV/EBITDA Sector rank

31.04%
ABVC EV/EBITDA is higher than 31.04% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.28
ABVC annual current ratio is 0.28

Quick ratio

-
ABVC annual quick ratio value is unknown

Leverage

Debt to equity

0.18
ABVC annual debt to equity ratio is 0.18

Interest coverage ratio

-3.27
ABVC annual interest coverage ratio is -3.27

Risk & Stability

Piotroski F-Score

3
ABVC piotroski f-score is 3

Altman Z-Score

-7.47
ABVC altman z-score is -7.47

Analyst ratings

Recent major analysts updates

Nov 16, 22 Maxim Group
Hold

Institutional Ownership

Similar stocks

TRIB logo
Trinity Biotech (TRIB)
ORGS logo
Orgenesis (ORGS)
BSGM logo
BioSig Technologies (BSGM)
RLYB logo
Rallybio (RLYB)
ICU logo
SeaStar Medical Holding (ICU)
MBRX logo
Moleculin Biotech (MBRX)
GOVX logo
GeoVax Labs (GOVX)
NERV logo
Minerva Neurosciences (NERV)
ERNA logo
Eterna Therapeutics (ERNA)
  • What is the ticker symbol for ABVC BioPharma?
  • Does ABVC BioPharma pay dividends?
  • What sector is ABVC BioPharma in?
  • What industry is ABVC BioPharma in?
  • What country is ABVC BioPharma based in?
  • When did ABVC BioPharma go public?
  • Is ABVC BioPharma in the S&P 500?
  • Is ABVC BioPharma in the NASDAQ 100?
  • Is ABVC BioPharma in the Dow Jones?
  • When was ABVC BioPharma's last earnings report?
  • When does ABVC BioPharma report earnings?
  • Should I buy ABVC BioPharma stock now?

What is the ticker symbol for ABVC BioPharma?

The ticker symbol for ABVC BioPharma is NASDAQ:ABVC

Does ABVC BioPharma pay dividends?

No, ABVC BioPharma does not pay dividends

What sector is ABVC BioPharma in?

ABVC BioPharma is in the Healthcare sector

What industry is ABVC BioPharma in?

ABVC BioPharma is in the Biotechnology industry

What country is ABVC BioPharma based in?

ABVC BioPharma is headquartered in United States

When did ABVC BioPharma go public?

ABVC BioPharma's initial public offering (IPO) was on November 10, 2004

Is ABVC BioPharma in the S&P 500?

No, ABVC BioPharma is not included in the S&P 500 index

Is ABVC BioPharma in the NASDAQ 100?

No, ABVC BioPharma is not included in the NASDAQ 100 index

Is ABVC BioPharma in the Dow Jones?

No, ABVC BioPharma is not included in the Dow Jones index

When was ABVC BioPharma's last earnings report?

ABVC BioPharma's most recent earnings report was on Nov 14, 2024

When does ABVC BioPharma report earnings?

The next expected earnings date for ABVC BioPharma is May 16, 2025

Should I buy ABVC BioPharma stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page